Background: Acne fulminans (AF) is a severe variant of inflammatory acne. It typically manifests as an explosive worsening and ulceration of skin lesions, and can be associated with systemic symptoms. However, there is a paucity of evidence-based information and no clear guidelines concerning the classification and treatment of AF.
Objective: To better define the spectrum of AF and its variants, devise optimal therapeutic approaches, and identify areas of future research.
Methods: A panel of physicians with expertise in severe acne vulgaris was convened after a comprehensive literature review of severe acne variants. Priority topics were reviewed and presented by each panelist at a 5-hour conference. Following review of the audiotape and scribed notes from the conference, surveys were utilized to address points of controversy and to clarify consensus recommendations.
Results: Appropriate clinical case presentations and consensus survey questions were utilized to create final recommendations based on both the literature and the expert consensus.
Limitations: Limited evidenced-based data and prospective studies in the literature concerning the treatment of AF is available.
Conclusion: These guidelines better characterize AF and provide health care practitioners approaches to the classification, treatment, and prevention of AF and its variants.
Keywords: PAPA; PAPASH; SAPHO; acne fulminans; diagnosis; isotretinoin; pseudotumor cerebri syndrome; treatment.
Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.